TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 6 | -2 | -15 | 67 | 133 | 126 | 52 |
| P | %wins | 67 | 50 | 50 | 50 | 50 | 50 | 53 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/19/25 16:01 | 5/19/25 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Katkin Keith | NY | D | P | 91 | 9.11 | 0 | 10 | 11 | 100 | D | |||||||||||||||
3/7/12 09:00 | 3/6/12 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Katkin Keith | CA | DO | P,CEO | P | 26 | 2.61 | 4 | 10 | 3 | 328 | D | 31 | -23 | -1 | 11 | -6 | -11 | -8 | -5 | 7 | |||||
2/25/09 15:34 | 2/24/09 | AVNR | Avanir Pharmaceuticals | CA | Health | Drug | Pharmaceutical Preparations | Katkin Keith | CA | DO | P,CEO | P | 7 | 0.4394 | 0 | 15 | 3 | 593 | -2 | -11 | 0 | 150 | 332 | 316 | |||||||||
5/25/06 20:44 | 5/25/06 | AVNR | Avanir Pharmaceuticals | CA | Health | Drug | Pharmaceutical Preparations | Katkin Keith | CA | O | SVP of S | P | 22 | 8.99 | 4 | 3 | New | 3 | 12 | 7 | -30 | -17 | -66 | -64 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |